Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “monoclonal”

203 pharma patents match "monoclonal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 203
Index total 30,257
Page 2 / 9

Quick answer

This filtered view shows 203 pharmaceutical patents matching "monoclonal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

203 results for “monoclonal” · 30,257 patents in full index Clear search

  1. US 11518812

    Monoclonal antibodies against HER2 epitope and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted

  2. US 11512141

    Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatment

    The Board of Regents of the University of Texas System · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted

  3. US 11505604

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

  4. US 11401341

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  5. US 11389480

    Human monoclonal antibody targeting TNFR2 for cancer immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted

  6. US 11377491

    Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer

    The Board of Regents of the University of Texas System · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  7. US 11370836

    Monoclonal antibody binding to human IL-5, preparation method therefor and use thereof

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  8. US 11352435

    Anti-CD133 monoclonal antibodies and related compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  9. US 11352417

    Method of treating an allergy with allergen-specific monoclonal antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  10. US 11254746

    Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  11. US 11236171

    Human monoclonal antibodies specific for FLT3 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  12. US 11208493

    Internalizing human monoclonal antibodies targeting prostate and other cancer cells

    The Regents of the University of California · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  13. US 11192958

    Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease

    The Board of Regents of the University of Texas System · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  14. US 11174320

    HER3 specific monoclonal antibodies for diagnostic and therapeutic use

    The Board of Regents of the University of Texas System · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted

  15. US 11078286

    Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  16. US 11066474

    Anti-TrkB monoclonal antibodies and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  17. US 11066479

    Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  18. US 11001641

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted May 11, 2021 · Expires May 6, 2041

    granted

  19. US 10961298

    Monoclonal antibodies for treatment of microbial infections

    The Government of the United States, represented by the Secretary of the Army · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  20. US 10954291

    Monoclonal antibodies that specifically bind to matrilin-3 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  21. US 10934360

    Human monoclonal antibodies against EPHA4 and their use

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  22. US 10875912

    EGFL6 specific monoclonal antibodies and methods of their use

    The Board of Regents of the University of Texas System · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  23. US 10781251

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

    Julius-Maximilians-Universitat Wurzburg · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  24. US 10738112

    Anti-human interleukin-17A monoclonal antibody

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.